BNP Paribas Financial Markets’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$985K Buy
71,921
+69,503
+2,874% +$952K ﹤0.01% 2210
2025
Q1
$26.7K Sell
2,418
-2,383
-50% -$26.4K ﹤0.01% 3625
2024
Q4
$51.1K Sell
4,801
-3,745
-44% -$39.9K ﹤0.01% 3572
2024
Q3
$109K Buy
8,546
+5,890
+222% +$74.8K ﹤0.01% 2712
2024
Q2
$44.6K Sell
2,656
-37,139
-93% -$623K ﹤0.01% 2796
2024
Q1
$597K Buy
39,795
+16,799
+73% +$252K ﹤0.01% 2128
2023
Q4
$345K Buy
22,996
+6,617
+40% +$99.3K ﹤0.01% 2308
2023
Q3
$229K Buy
16,379
+11,277
+221% +$158K ﹤0.01% 2379
2023
Q2
$52.8K Buy
5,102
+4,925
+2,782% +$51K ﹤0.01% 2833
2023
Q1
$1.64K Sell
177
-1,104
-86% -$10.2K ﹤0.01% 3016
2022
Q4
$11.4K Sell
1,281
-50
-4% -$443 ﹤0.01% 2938
2022
Q3
$11.1K Sell
1,331
-6,249
-82% -$52K ﹤0.01% 3458
2022
Q2
$62.1K Buy
7,580
+5,881
+346% +$48.2K ﹤0.01% 2869
2022
Q1
$14.8K Sell
1,699
-2,794
-62% -$24.3K ﹤0.01% 3185
2021
Q4
$42.7K Buy
4,493
+934
+26% +$8.88K ﹤0.01% 3122
2021
Q3
$59.9K Buy
3,559
+2,785
+360% +$46.8K ﹤0.01% 2868
2021
Q2
$11.8K Sell
774
-3,665
-83% -$56K ﹤0.01% 3084
2021
Q1
$86.5K Buy
4,439
+657
+17% +$12.8K ﹤0.01% 2853
2020
Q4
$68.2K Sell
3,782
-806
-18% -$14.5K ﹤0.01% 2759
2020
Q3
$88.5K Buy
4,588
+3,521
+330% +$67.9K ﹤0.01% 2570
2020
Q2
$27.9K Sell
1,067
-5,031
-83% -$131K ﹤0.01% 2637
2020
Q1
$109K Buy
6,098
+3,605
+145% +$64.3K ﹤0.01% 2554
2019
Q4
$83.2K Sell
2,493
-866
-26% -$28.9K ﹤0.01% 2711
2019
Q3
$80K Buy
+3,359
New +$80K ﹤0.01% 2612